GenMark Diagnostics Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (31)

Latest Posts

About This Stock More About This Stock
Report From J.P.Morgan Healthcare Conference 2021: Current Portfolio Positions #1
Article By: Rod Raynovich
Thursday, January 14, 2021 5:42 AM EDT
The Conference boosted many stocks as you might expect in a bull market for biotech. We reviewed rather quickly some of the presentations from the JPMorgan Healthcare Conference and will comment on specific companies and stocks in a series of posts.
In this article: ABT, BMY, GNMK, IBB, HOLX, PACB, XBI, ABBV, AXDX, GKOS, TDOC, VIR Also: AZN, GSK, MRNA, BNTX, JPM
Read
Biotech Stock Playbook In A Choppy Momentum Market
Article By: Rod Raynovich
Tuesday, September 29, 2020 4:57 AM EDT
Biotech stocks peaked in mid-July but we have assumed a fourth quarter rally driven by clinical news in oncology and important scientific breakthroughs in diagnostic testing for coronavirus and COVID vaccine data.
In this article: ABT, AZN, BMY, GSK, JNJ, MRK, RHHBY, GNMK, NVAX, OSUR, QDEL, HOLX, PACB, ABBV, AXDX, EDIT, CRSP
Read
GenMark Prices Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Wednesday, May 6, 2020 3:48 PM EDT
GenMark Diagnostics, Inc., today announced the pricing of its previously announced underwritten public offering of 7,253,886 shares of its common stock at a public offering price of $9.65 per share.
In this article: GNMK
Read
Coronavirus Update - Some Stock Picks For The Pandemic
Article By: Paradigm Press
Thursday, March 26, 2020 12:43 PM EDT
There are so many coronavirus related plays right now. As the market is crashing (despite rebounding today), coronavirus stocks are hot. Here are a few examples from last Friday’s market close…
In this article: TNXP, MEDS, NBDR, GNMK, BLPH, GAXY, XSPA
Read
GenMark Diagnostics Files For Emergency Use Authorization For COVID-19 Test
Article By: Benzinga
Wednesday, March 11, 2020 11:37 AM EDT
GenMark Diagnostics, Inc shares are headed higher again following an update from the company regarding its COVID-19 diagnostics test.
In this article: GNMK
Read

Latest Tweets for $GNMK

No tweets yet!

PARTNER HEADLINES